Clinical Trial Update: Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study of BKM 120 (buparlisib) in combination with LH-RH agonists and bicalutamide in men with non-castrate metastatic prostate cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BKM-120 (buparlisib)
• Luteinizing hormone-releasing hormone agonist (LHRH agonist)
• bicalutamide (bicalutamide)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Non Castrate Metastatic Prostate Cancer | Phase 1 | Status: TERMINATED